Abstract
A potential anticancer heterodinuclear ruthenium(II)–platinum(II) complex, [ruthenium(II)(4,4′-dimethyl-2,2′-bipyridine)2(5-(l-cysteine-methyl ester)-1,10-phenanthroline)-trans-chlorodiammineplatinum(II)] chloride, [Ru(Me2bipy)2(5-(l-cysteine-Me)-phen)-trans-Pt(NH3)2Cl]Cl3, was synthesised. l-Cysteine methyl ester was used to link the two metal centres, as more conventional straight chain diaminoalkanes and 2-mercaptoethylamine failed to couple to the phenanthroline ligand. From the precursor mononuclear ruthenium(II) complexes, which were separated into their Δ- and Λ-isomers by column chromatography, the dinuclear complex was synthesised and characterised by 1H and 13C NMR, UV–Vis, circular dichroism, fluorescence and electrospray ionisation mass spectrometry.
| Original language | English |
|---|---|
| Pages (from-to) | 318-328 |
| Number of pages | 11 |
| Journal | Polyhedron |
| Volume | 26 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - 22 Jan 2007 |
| Externally published | Yes |
Keywords
- L-cysteine methyl ester
- Anticancer
- Heterodinuclear
- Phenanthroline
- Platinum(II)
- Ruthenium(II)
Fingerprint
Dive into the research topics of 'Synthesis of a heterodinuclear ruthenium(II)-platinum(II) complex linked by L-cysteine methyl ester'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver